Mitomycin-C-Induced TTPHUS Treated Successfully with Rituximab : Case Report and Review of the Literature

Abstract EN

Microangiopathic hemolytic anemia (MAHA), thrombocytopenia, fever, renal failure, and neurologic symptoms comprise the cardinal features of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.

Etiologies can include medications, infections, cancers, or transplantation.

We present a patient with a history of rectal cancer treated with mitomycin-C who developed MAHA, acute kidney injury, and thrombocytopenia 6 months after completing therapy and to did not respond the plasmapheresis or steroids.

She was treated with four weekly doses of rituximab with full recovery.